Novo Nordisk (alt)
Novo Nordisk (alt)
Share · DK0060534915 · A1XA8R (LSSI)
Note: On 09/13/2023 due to a stock split, this security was replaced by DK0062498333
Overview
No Price
16.01.2026 20:59
Invested Funds

The following funds have invested in Novo Nordisk (alt):

Fund
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in million
4.437,90
Percentage (%)
10,16 %
Fund
iShares Edge MSCI Europe Quality Factor UCITS ETF EUR (Dist)
Vol. in million
250,88
Percentage (%)
5,84 %
Fund
iShares MSCI Europe SRI UCITS ETF USD (Acc)
Vol. in million
1.972,07
Percentage (%)
4,23 %
Fund
iShares MSCI Europe SRI UCITS ETF EUR Hedged (Dist)
Vol. in million
2.483,21
Percentage (%)
4,23 %
Fund
iShares MSCI Europe SRI UCITS ETF EUR (Dist)
Vol. in million
29.740,69
Percentage (%)
4,23 %
Company Profile for Novo Nordisk (alt) Share
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
AI Analysis of Novo Nordisk (alt)
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Novo Nordisk (alt)
No AI threads available for this company yet.

Company Data

Name Novo Nordisk (alt)
Company Novo Nordisk A/S
Website https://www.novonordisk.com
Primary Exchange LSSI Lang & Schwarz
WKN A1XA8R
ISIN DK0060534915
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Lars Fruergaard Jorgensen
Market Capitalization 407 Mrd.
Country Denmark
Currency EUR
Employees 59,3 T
Address Novo Alle, Bagsvaerd
IPO Date 2001-06-07

Stock Splits

Date Split
13.09.2023 2:1

Ticker Symbols

Name Symbol
XETRA NOVC.DE
More Shares
Investors who hold Novo Nordisk (alt) also have the following shares in their portfolio:
ALLIANZ AG
ALLIANZ AG Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BANK VONTOBEL/CALL/MICROSTRATEGY INC. CLASS A
BANK VONTOBEL/CALL/MICROSTRATEGY INC. CLASS A Optionsscheine
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Share
JOHNSON & JOHNSON
JOHNSON & JOHNSON Share
KG + BAUER AG ST
KG + BAUER AG ST Share
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NANOSPHERE HEA.SCIENCES
NANOSPHERE HEA.SCIENCES Share
Novo Nordisk
Novo Nordisk Share
TAAT LIFESTYLE+WELLNESS
TAAT LIFESTYLE+WELLNESS Share
TESLA INC
TESLA INC Share
UNILEVER PLC
UNILEVER PLC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026